Biocon Limited (NSE:BIOCON)
India flag India · Delayed Price · Currency is INR
426.00
+0.65 (0.15%)
Jul 31, 2026, 3:30 PM IST

Biocon Company Description

Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally.

It operates through Generics; Biosimilars; and Contract Research, Development and Manufacturing Organization (CRDMO) segments.

The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, central nervous system, anti-cancer/oncology, multiple sclerosis, immunosuppressants, and specialty molecules; and biosimilars products for oncology, diabetes, and immunology therapeutic areas.

It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal health, consumer goods, and specialty chemical industries, as well as academic institutions, non-profit organizations, and government agencies.

In addition, the company offers enzyme, biopharmaceutical, and medicinal goods; contract research and manufacturing services; clinical research; and business support and development, and marketing services.

Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.

Biocon Limited
Biocon logo
CountryIndia
Founded1978
IndustryBiotechnology
SectorHealthcare
Employees16,447
CEOShreehas Tambe

Contact Details

Address:
20th KM, Hosur Road
Bengaluru, Karnataka 560100
India
Phone91 80 2808 2808
Websitebiocon.com

Stock Details

Ticker SymbolBIOCON
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE376G01013
SIC Code2836

Key Executives

NamePosition
Shreehas Pradeep Tambe MTechChief Executive Officer, MD and Additional Director
Dr. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc.Founder and Executive Chairperson
Kedar Narayan Upadhye CS, MBAChief Financial Officer
Dr. Mandar S. GhatnekarChief Technology Officer
Saurabh PaliwalHead of Investor Relations
Rajesh Umakant ShanoyCompany Secretary and Compliance Officer
Seema Shah Ahuja BA, MBASVice President and Global Head Corporate Communications & Corporate Brand Biocon Group
Naveen NarayananChief Human Resources Officer
Dr. Anuj GoelChief Development Officer
Paul Vazhayil ThomasChief Commercial Officer, U.S. and Portfolio Strategy & Business Dev, Adv mkts of Biosimilars Business